Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy

This study was to evaluate the prognostic significance of serum lipids in esophageal squamous cell carcinoma patients who underwent esophagectomy. Preoperative serum lipids were collected from 214 patients who were diagnosed with esophageal squamous cell carcinoma. All of the patients received esophagectomy in Qilu Hospital of Shandong University from January 2007 to December 2008. The records and data were analyzed retrospectively. We found that low total cholesterol (for T stage, p = 0.006; for TNM stage, p = 0.039) and low-density lipoprotein cholesterol (for T stage, p = 0.031; for TNM stage, p = 0.035) were associated with advanced T stage and TNM stage. Kaplan-Meier survival analysis indicated that low total cholesterol and low-density lipoprotein cholesterol were associated with shorter disease-free survival(for total cholesterol, p = 0.045; for low-density lipoprotein cholesterol, p < 0.001) and overall survival (for total cholesterol, p = 0.043; for low-density lipoprotein cholesterol, p < 0.001). Lower low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio (LHR) indicated poorer disease-free survival and overall survival (both p < 0.001). In the multivariate analysis, low-density lipoprotein cholesterol and LHR were independent prognostic factors for disease-free survival and overall survival. In conclusion, our study indicated that preoperative serum total cholesterol and low-density lipoprotein cholesterol are prognostic factors for esophageal squamous cell carcinoma patients who underwent esophagectomy. LHR can serve as a promising serum lipids-based prognostic indicator.

[1]  Jun Ma,et al.  High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma , 2016, Oncotarget.

[2]  L. Holmberg,et al.  Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis , 2015, BMC Cancer.

[3]  T. H. Bø,et al.  Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses , 2015, Oncotarget.

[4]  D. Hermann,et al.  LDL suppresses angiogenesis through disruption of the HIF pathway via NF-κB inhibition which is reversed by the proteasome inhibitor BSc2118 , 2015, Oncotarget.

[5]  E. Harris,et al.  Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome , 2015, PLoS neglected tropical diseases.

[6]  N. Boyd,et al.  Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. , 2015, Journal of the National Cancer Institute.

[7]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[8]  D. Matchar,et al.  Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey. , 2015, Atherosclerosis.

[9]  Yi Wang,et al.  Human cancer: is it linked to dysfunctional lipid metabolism? , 2015, Biochimica et biophysica acta.

[10]  Xu,et al.  Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area , 2014, OncoTargets and therapy.

[11]  Hao Li,et al.  The Variability of oxLDL-induced Cytotoxicity on Different Types of Cell Lines , 2013, Cell Biochemistry and Biophysics.

[12]  F. Irie,et al.  Low serum LDL cholesterol levels are associated with elevated mortality from liver cancer in Japan: the Ibaraki Prefectural health study. , 2013, The Tohoku journal of experimental medicine.

[13]  D. Rao,et al.  Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  John Simes,et al.  Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy , 2012, PloS one.

[15]  Hao Li,et al.  The effect of oxidized low-density lipoprotein combined with adriamycin on the proliferation of Eca-109 cell line , 2011, Lipids in Health and Disease.

[16]  Anne Tybjærg-Hansen,et al.  Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. , 2011, Journal of the National Cancer Institute.

[17]  L. Qin,et al.  Serum LDL-C and LDL-C/HDL-C ratio are positively correlated to lymph node stages in males with colorectal cancer. , 2011, Hepato-gastroenterology.

[18]  K. Kayaba,et al.  Low Cholesterol is Associated With Mortality From Stroke, Heart Disease, and Cancer: The Jichi Medical School Cohort Study , 2010, Journal of epidemiology.

[19]  F. Chang,et al.  Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan , 2010, Cancer Causes & Control.

[20]  L. Atzori,et al.  Serum lipoproteins and cancer. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[21]  Yan Wang,et al.  Relationship between oxidized LDL antibodies and different stages of esophageal carcinoma. , 2008, Archives of medical research.

[22]  S. Horvath,et al.  Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma , 2005, Cancer.

[23]  M. Matsuda,et al.  Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study. , 2004, Journal of experimental & clinical cancer research : CR.

[24]  E. Chavakis,et al.  Oxidized LDL Inhibits Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration by an Inhibitory Effect on the Akt/Endothelial Nitric Oxide Synthase Pathway , 2001, Circulation.

[25]  D. Axelson,et al.  Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. , 2000, Anticancer research.

[26]  N. Boyd,et al.  Plasma lipids, lipoproteins, and mammographic densities. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  S. Yusuf,et al.  Report of the Conference on Low Blood Cholesterol: Mortality Associations , 1992, Circulation.

[28]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[29]  P. Toth.  Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy , 2012 .

[30]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.